glp-1 for insulin resistance Endogenous Activation of Glucagon-Like Peptide-1 Receptor Contributes to Blood Pressure Control Fighting insulin resistance? GLP-1s help

Subrahmanyan NA, Koshy RM, Jacob K, Pappachan JM (2021) Efficacy and cardiovascular safety of DPP-4 inhibitors

Patients with kidney disease, cardiovascular disease, liver conditions, or a history of eating disorders should avoid highly restrictive diets unless supervised medically

Shared layouts, interface elements, and payment processing systems provide strong evidence that scammers are deploying pre-packaged website kits to rapidly establish fake clinic storefronts

Specifically, the proposed tariffs could worsen existing drug shortages in the U.S., especially for generic medications, given that 70 to 80% of generic drugs are manufactured or sourced internationally

Put your fork down between bites

Literature shows that DPP4is have a promising safety profile in comparison with other oral antidiabetic medications, however, certain safety aspects require additional exploration